Separately, J P Morgan Chase & Co set a CHF 70 price target on shares of Novartis AG and gave the company a neutral rating in a research report on Saturday, May 20th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the stock. The stock has a consensus rating of Hold and an average price target of CHF 78.
Shares of Novartis AG (VTX:NOVN) traded up 1.41% during mid-day trading on Friday, reaching CHK 79.20. The company’s stock had a trading volume of 4,417,612 shares. Novartis AG has a 52 week low of CHK 67.40 and a 52 week high of CHK 82.80. The firm has a 50-day moving average of CHK 78.71 and a 200-day moving average of CHK 75.17.
TRADEMARK VIOLATION NOTICE: This article was posted by BBNS and is the property of of BBNS. If you are reading this article on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The original version of this article can be viewed at https://baseballnewssource.com/markets/novartis-ag-novn-pt-set-at-chf-80-by-goldman-sachs-group-inc-updated-updated-updated/804354.html.
Novartis AG Company Profile
Novartis AG is a holding company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. The Company’s segments include Innovative Medicines, Sandoz, Alcon and Corporate activities.
Receive News & Ratings for Novartis AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novartis AG and related companies with our FREE daily email newsletter.